Scott Jeffrey Riley

Affiliations

  • Director at Gain Therapeutics Inc. (GANX), 2025-06-25
  • Chief Executive Officer at Synthetic Biologics Inc. (SYN), 2016-12-02
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
GANX $3.86 30,000 $115,770.00 30,000 2024-03-28 Filing
SYN $0.17 2,895 $497.94 10,400 2013-01-07 Filing
SYN $1.71 5 $8.55 7,505 2013-01-07 Filing
SYN $1.71 2,000 $3,420.00 7,500 2013-01-03 Filing
SYN $1.75 2,800 $4,899.72 5,500 2013-01-03 Filing